Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Precision medicine

Diagnostics Genetics and epigenetics

Testing for Gene Fusions

| Sponsored by Thermo Fisher Scientific

A comparison of commonly used NGS assays for the detection of fusion genes based on a recent educational webinar

Inside the Lab Laboratory management

Pathologists: In-House Experts

| Sponsored by Thermo Fisher Scientific

An interview with Ruthy Shaco-Levy to explore why in-house laboratory is a valuable resource for both clinicians and patients

Diagnostics Genetics and epigenetics

A Thorough NUDT15 Variant Catalogue

| Michael Schubert

Researchers have catalogued almost every NUDT15 variant to understand patients’ likelihood of thiopurine toxicity

Diagnostics Genetics and epigenetics

Precision Medicine: The Next Generation

| David Fenstermacher

Precision medicine is creating a sea change in healthcare and biomedical research. Is your lab prepared for the approaching tsunami of genetic tests?

Diagnostics Liquid biopsy

Test, Treat, Repeat

| Alexandra Pender, Natacha Entz-Werle

New ctDNA biomarkers could lead to more informed treatment decisions for patients with advanced non-small cell lung cancer and pediatric osteosarcoma

Diagnostics Genetics and epigenetics

Boosting Genomic Research in Africa

| Luke Turner

A new initiative for translational genomics is set to boost genetic research and inspire the next generation of scientists in Africa

Diagnostics Companion diagnostics

Atezolizumab Assay Angst

| David Rimm

David Rimm continues the conversation about the best assay for atezolizumab after a recent response to his original article

Diagnostics Genetics and epigenetics

What is the Real Impact?

| Sponsored by Thermo Fisher Scientific

How valuable can it be to receive fully automated NGS results in a single day? A group of experts share their views

Diagnostics Genetics and epigenetics

On NTRK and Other Fusion Biomarkers

| Fernando Lopez-Rios

Next-generation sequencing is changing the future of precision oncology with its ability to test for NTRK gene fusions and more

Diagnostics Precision medicine

Deep Bio’s Deep Dive

| Sponsored by Deep Bio

AI diagnostics offer great potential for the future – and as a disease of many challenges, prostate cancer is a great first target

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register